Just trading and things
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CELZ at bottom! .0031 with 52 week high of .70 No dilution left! Low floater! Real product! 2018 they generate revenue in this industry that is worth billions!
CELZ = definition of a sleeper? They are just rolling out operations on their natural remedy 4 ED using Stem Cells. Huge upside here my man. Clinical trials give it a green light.
I put float around 60m at most if new OS went in public. AS was just raised so should keep that in mind.
Plan of Operations
We anticipate that if our clinical studies on our ED stem cell treatment are successful, we can commence marketing kits for the treatment in 2018. For the next 12 months our plan of operations is to complete these clinical trials and commence marketing of the kits. We estimate the costs to complete the clinical trials will be approximately $500,000, excluding overhead and other costs associated with maintaining our company structure. We believe that our current cash on hand would meet our cash flow requirements for only a few more months. If we are unable to obtain further financing, we may seek alternative sources of funding or revise our business plan. We currently have no alternative sources for funding.
Safety and Efficacy of Caverstem TM Procedure
On October 18, 2017 we announced the completion of the safety data analysis on 20 patients in our erectile dysfunction clinical trial. Based on establishment of safety of the CaverStem TM procedure in a formal university-based clinical trial, and independent confirmation of efficacy in a European clinical trial we launched commercialization for the Caverstem TM procedure.
(January 31, 2018 – Phoenix, AZ) Creative Medical Technology Holdings Inc. (OTCQB ticker symbol CELZ) announced today the continued positive response and recruitment of physicians for its patented and clinically tested Caverstem™ procedure for the treatment of erectile dysfunction using the patient’s own bone marrow derived stem cells.
“Since commercialization of our Caverstem™ procedure began in December 2017, we’re pleased that our early results in bringing in experienced medical doctors in our initial area of sales in the Southwest United States has been very positive. Recruitment of medical doctors in Los Angeles, Orange County, San Diego and Las Vegas NV is just the start of what we believe will be a rapid growth as we expand into other areas of the country” said Timothy Warbington, CEO of Creative Medical Technology Holdings, Inc.
“Patient understanding and interest in our stem cell technology has also been positive. The physicians involved with the Caverstem™ procedure are treating patients and as the patient outreach is expanded we are excited by the ongoing and increased growth in the number of patient’s seeking our treatment.”
Approximately 30% of the 30,000,000 patients suffering from erectile dysfunction do not respond to drugs like Viagra, Cialis and Levitra, in part due to an underlying degeneration of the biological machinery needed to achieve erections. The Caverstem™ procedure is a natural alternative for many of these patients.
“There is much excitement about stem cells revolutionizing many aspects of medicine. I am enthusiastic to be treating my patients using this cutting edge procedure,” Stated by Dr. Alexander Gershman. “Numerous publications and a recent clinical trial at the Los Angeles Biomedical Institute at Harbor – UCLA Hospital in Torrance, CA, support the safety and feasibility of the Caverstem™ procedure. The biological basis of the bone marrow based treatment is that in patients with drug non-responsive erectile dysfunction, there is a deficit in function of smooth muscle and blood vessel cells. By administering the patient’s own stem cells we aim to rebuild these damaged tissues, and thereby restore erectile function.”
“We are pleased that after several years of development and testing we are now realizing the overwhelming acceptance of our Caverstem™ procedure by highly credible physicians and their patients.” Said Thomas Ichim PhD, co-inventor of the Caverstem™ procedure and Director of Creative Medical Technology Holdings Inc.
$CELZ at bottom! .0031 with 52 week high of .70 No dilution left! Low floater! Real product! 2018 they generate revenue in this industry that is worth billions!
CELZ = definition of a sleeper? They are just rolling out operations on their natural remedy 4 ED using Stem Cells. Huge upside here my man. Clinical trials give it a green light.
I put float around 60m at most if new OS went in public. AS was just raised so should keep that in mind.
Plan of Operations
We anticipate that if our clinical studies on our ED stem cell treatment are successful, we can commence marketing kits for the treatment in 2018. For the next 12 months our plan of operations is to complete these clinical trials and commence marketing of the kits. We estimate the costs to complete the clinical trials will be approximately $500,000, excluding overhead and other costs associated with maintaining our company structure. We believe that our current cash on hand would meet our cash flow requirements for only a few more months. If we are unable to obtain further financing, we may seek alternative sources of funding or revise our business plan. We currently have no alternative sources for funding.
Safety and Efficacy of Caverstem TM Procedure
On October 18, 2017 we announced the completion of the safety data analysis on 20 patients in our erectile dysfunction clinical trial. Based on establishment of safety of the CaverStem TM procedure in a formal university-based clinical trial, and independent confirmation of efficacy in a European clinical trial we launched commercialization for the Caverstem TM procedure.
(January 31, 2018 – Phoenix, AZ) Creative Medical Technology Holdings Inc. (OTCQB ticker symbol CELZ) announced today the continued positive response and recruitment of physicians for its patented and clinically tested Caverstem™ procedure for the treatment of erectile dysfunction using the patient’s own bone marrow derived stem cells.
“Since commercialization of our Caverstem™ procedure began in December 2017, we’re pleased that our early results in bringing in experienced medical doctors in our initial area of sales in the Southwest United States has been very positive. Recruitment of medical doctors in Los Angeles, Orange County, San Diego and Las Vegas NV is just the start of what we believe will be a rapid growth as we expand into other areas of the country” said Timothy Warbington, CEO of Creative Medical Technology Holdings, Inc.
“Patient understanding and interest in our stem cell technology has also been positive. The physicians involved with the Caverstem™ procedure are treating patients and as the patient outreach is expanded we are excited by the ongoing and increased growth in the number of patient’s seeking our treatment.”
Approximately 30% of the 30,000,000 patients suffering from erectile dysfunction do not respond to drugs like Viagra, Cialis and Levitra, in part due to an underlying degeneration of the biological machinery needed to achieve erections. The Caverstem™ procedure is a natural alternative for many of these patients.
“There is much excitement about stem cells revolutionizing many aspects of medicine. I am enthusiastic to be treating my patients using this cutting edge procedure,” Stated by Dr. Alexander Gershman. “Numerous publications and a recent clinical trial at the Los Angeles Biomedical Institute at Harbor – UCLA Hospital in Torrance, CA, support the safety and feasibility of the Caverstem™ procedure. The biological basis of the bone marrow based treatment is that in patients with drug non-responsive erectile dysfunction, there is a deficit in function of smooth muscle and blood vessel cells. By administering the patient’s own stem cells we aim to rebuild these damaged tissues, and thereby restore erectile function.”
“We are pleased that after several years of development and testing we are now realizing the overwhelming acceptance of our Caverstem™ procedure by highly credible physicians and their patients.” Said Thomas Ichim PhD, co-inventor of the Caverstem™ procedure and Director of Creative Medical Technology Holdings Inc.
$$$ CELZ REVERSAL HUUUUUUGGGGGE!! Bottom in. BOOOOOOOOOOOOM
$$$ CELZ REVERSAL HUUUUUUGGGGGE!! Bottom in. BOOOOOOOOOOOOM
Well that is a given! We will be back over a penny in no time.
$CELZ .003 currently. You will not find a better opportunity in the OTC. Was .70 a year ago! They have stated 2018 they will be commercializing there main product a drug for erectile defunction. A drug worth upward of Billions as traditional current drugs do not work on roughly 33% of the worlds population. This stem cell research company is the future and with a market cap of only 300 thousand there is A LOT of room to run! Other companies in the same field and research status has a market cap upward of 800 million to over a billion depending on the company. They also have other drugs they are working on! This is a steal at these prices sitting at the all time low. This will pop to new highs soon!
$CELZ .003 currently. You will not find a better opportunity in the OTC. Was .70 a year ago! They have stated 2018 they will be commercializing there main product a drug for erectile defunction. A drug worth upward of Billions as traditional current drugs do not work on roughly 33% of the worlds population. This stem cell research company is the future and with a market cap of only 300 thousand there is A LOT of room to run! Other companies in the same field and research status has a market cap upward of 800 million to over a billion depending on the company. They also have other drugs they are working on! This is a steal at these prices sitting at the all time low. This will pop to new highs soon!
I can promise you this does not go below .0025 the all time low.
There is a lot of time in a trading day.
$CELZ reverse occurring! .05++++ coming! Will go higher than last time! The RSI has cooled down. Company itself is a research company that is now commercializing a step cell procedure that is worth billions. They also have several other drugs in the works. This is a company that you do not want to miss and with a all time high of .70 this has the potential to cross dollars short term.
$CELZ reverse occurring! .05++++ coming! Will go higher than last time! The RSI has cooled down. Company itself is a research company that is now commercializing a step cell procedure that is worth billions. They also have several other drugs in the works. This is a company that you do not want to miss and with a all time high of .70 this has the potential to cross dollars short term.
$CELZ reverse occurring! .05++++ coming! Will go higher than last time! The RSI has cooled down. Company itself is a research company that is now commercializing a step cell procedure that is worth billions. They also have several other drugs in the works. This is a company that you do not want to miss and with a all time high of .70 this has the potential to cross dollars short term.
No we will see green today! Should test .005
$CELZ is oversold from a technical aspect! On top of that it is a company entering a space never before seen with stem cells. If that was not enough they have a actual product that is being commercialized and sold starting in 2018! 33% of the worlds population cannot use current ED but they can with this new and safe method! If that is not enough they have world renounced doctors on board researching other new methods. Stem Cells are the future and with levels near all time low this is a stock getting worth into before it jumps back over a penny! I see this being much higher than that with my initial PT: .20 and wayyyyy over $1 by end of year. This is one you want in your portfolio and right now is a fantastic entry point.
$CELZ is oversold from a technical aspect! On top of that it is a company entering a space never before seen with stem cells. If that was not enough they have a actual product that is being commercialized and sold starting in 2018! 33% of the worlds population cannot use current ED but they can with this new and safe method! If that is not enough they have world renounced doctors on board researching other new methods. Stem Cells are the future and with levels near all time low this is a stock getting worth into before it jumps back over a penny! I see this being much higher than that with my initial PT: .20 and wayyyyy over $1 by end of year. This is one you want in your portfolio and right now is a fantastic entry point.
WRONG! The key word is that it is there policy. Ask them about any of the tickers they do and I bet you get the same reply! It doesn't mean anything.
$CELZ set to be a big runner in 2018!
BIG NEWS CAN COME ANY DAY AND A BUYOUT IS ALWAYS POSSIBLE BY MAJOR COMPANIES!
https://www.otcmarkets.com/stock/CELZ/news/Creative-Medical-Technology-Holdings-Licenses-Intellectual-Property-from-Internationally-Renowned-Neurologist-and-Create?id=183819
" Dr. Ichim has been responsible for 3 FDA cleared Investigational New Drug (IND) Applications in the area of cellular therapy and is inventor of over 100 patents and patent applications."
There main drug of course Caverstem™ Stem Cell Procedure is now going through commercialization and is set to generate revenue this year. This will be a revolutionary year for this QB OTC company and is entering a field worth billions! At these prices it is well worth getting in as we are sitting near all time lows. This was .70 just a year ago and only a fool would not get in at these levels. This is a research company and it is clear they have a bright future for both investors and the company itself. 33% of people cannot use current ED methods and this solves that problem which could generate billions and if you add that with the other cures they are researching this is a hidden diamond!
$CELZ set to be a big runner in 2018!
BIG NEWS CAN COME ANY DAY AND A BUYOUT IS ALWAYS POSSIBLE BY MAJOR COMPANIES!
https://www.otcmarkets.com/stock/CELZ/news/Creative-Medical-Technology-Holdings-Licenses-Intellectual-Property-from-Internationally-Renowned-Neurologist-and-Create?id=183819
" Dr. Ichim has been responsible for 3 FDA cleared Investigational New Drug (IND) Applications in the area of cellular therapy and is inventor of over 100 patents and patent applications."
There main drug of course Caverstem™ Stem Cell Procedure is now going through commercialization and is set to generate revenue this year. This will be a revolutionary year for this QB OTC company and is entering a field worth billions! At these prices it is well worth getting in as we are sitting near all time lows. This was .70 just a year ago and only a fool would not get in at these levels. This is a research company and it is clear they have a bright future for both investors and the company itself. 33% of people cannot use current ED methods and this solves that problem which could generate billions and if you add that with the other cures they are researching this is a hidden diamond!
https://www.otcmarkets.com/stock/CELZ/news/Creative-Medical-Technology-Holdings-Licenses-Intellectual-Property-from-Internationally-Renowned-Neurologist-and-Create?id=183819
" Dr. Ichim has been responsible for 3 FDA cleared Investigational New Drug (IND) Applications in the area of cellular therapy and is inventor of over 100 patents and patent applications."
There main drug of course Caverstem™ Stem Cell Procedure is now going through commercialization and is set to generate revenue this year. This will be a revolutionary year for this QB OTC company and is entering a field worth billions! At these prices it is well worth getting in as we are sitting near all time lows. This was .70 just a year ago and only a fool would not get in at these levels. This is a research company and it is clear they have a bright future for both investors and the company itself. 33% of people cannot use current ED methods and this solves that problem which could generate billions and if you add that with the other cures they are researching this is a hidden diamond!
oH PLEASE THEY WILL NOT r/s this. that is the oldest scare tatic in the books!
Actually yes I have and like I said pros outweigh the cons. We are talking about a real company with real product. They have already said 2018 is the year they are commercializing the product they have poured money into. This product have the potential to generate billions in revenue as 33% of people cannot or are not able to take other ED drugs. This is a good alternate for many people and trials shows it works. So if I have to eat through a little dilution so be it. But this is a modern breakthrough drug. So even if they must dilute all 3 billion AS. Which I do not think they will. I am confident this can and will trade over $1 in the near future!
Know what you own. This is a stock that will be trading much higher. Do not get spooked by people who wish to get in at a lower price or those who may be short this stock.
It was already official weeks ago.
I didn't say anything about Friday but thank you for your input xD
I'll wager this is green tomorrow. We are heading to a test of .01 once again!
There is only one scam here and it isn't this stock.
Not true at all.
Nothing we didn't already know. Just letting us know that the 3 billion is now the new A/S which was expected.
We anticipate that if our clinical studies on our ED stem cell treatment are successful, we can commence marketing kits for the treatment in 2018. For the next 12 months our plan of operations is to complete these clinical trials and commence marketing of the kits.
I will. I have seen plenty of otc stocks with no dilution that t-trade
Ok and that is.... what
Do you have a point?
Maybe just maybe we think the pros outweigh the cons?
Well....shit when do we bottom out?!
That ask is thinnnnnnn
Let's see some green!
I think we found the bottom today!
cool. You must be so proud....
I think we may have finally found the bottom :D also BMIC moved back to .037
this stock is under a massive short attack, Many of the bearish posts on this site today support that.